166 related articles for article (PubMed ID: 33811964)
1. Understanding the effect of counterpressure buildup during syringe injections.
Shahriar M; Rewanwar A; Rohilla P; Marston J
Int J Pharm; 2021 Jun; 602():120530. PubMed ID: 33811964
[TBL] [Abstract][Full Text] [Related]
2. Characterization of needle-assisted jet injections.
Li X; Ruddy B; Taberner A
J Control Release; 2016 Dec; 243():195-203. PubMed ID: 27746273
[TBL] [Abstract][Full Text] [Related]
3. Prefilled Syringe Injection Force Impact Assessment from Back Pressure: An Approach for Testing Syringe Injectability In Situ vs. In Vitro.
Megna C; Wells O; Bonanno D; Rasheed W; Cristofolli E
PDA J Pharm Sci Technol; 2023; 77(5):340-349. PubMed ID: 37188533
[TBL] [Abstract][Full Text] [Related]
4. Injectability as a function of viscosity and dosing materials for subcutaneous administration.
Watt RP; Khatri H; Dibble ARG
Int J Pharm; 2019 Jan; 554():376-386. PubMed ID: 30414478
[TBL] [Abstract][Full Text] [Related]
5. Influence of hypodermic needle dimensions on subcutaneous injection delivery--a pig study of injection deposition evaluated by CT scanning, histology, and backflow.
Juul KA; Bengtsson H; Eyving B; Kildegaard J; Lav S; Poulsen M; Serup J; Stallknecht B
Skin Res Technol; 2012 Nov; 18(4):447-55. PubMed ID: 22233448
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous nicotine delivery via needle-free jet injection: A porcine model.
Ruddy BP; Bullen C; Chu JTW; Jeong SH; Madadkhahsalmassi B; McKeage JW; Svirskis D; Tingle MD; Xu J; Taberner AJ
J Control Release; 2019 Jul; 306():83-88. PubMed ID: 31150748
[TBL] [Abstract][Full Text] [Related]
7. Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV).
Jarrahian C; Rein-Weston A; Saxon G; Creelman B; Kachmarik G; Anand A; Zehrung D
Vaccine; 2017 Mar; 35(14):1789-1796. PubMed ID: 28189403
[TBL] [Abstract][Full Text] [Related]
8. Gas-powered jet injection compared with conventional methods of injection using lignocaine and technetium-99m.
Cooke ED; Bowcock SA; Johnston A; Elliott AT
Br Med J; 1980 Sep; 281(6241):643-4. PubMed ID: 7437747
[TBL] [Abstract][Full Text] [Related]
9. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
[TBL] [Abstract][Full Text] [Related]
10. Delivery of immunoreactive antigen using a controllable needle-free jet injector.
Hogan NC; Anahtar MN; Taberner AJ; Hunter IW
J Control Release; 2017 Jul; 258():73-80. PubMed ID: 28479095
[TBL] [Abstract][Full Text] [Related]
11. Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.
Aylward B; Lloyd J; Zaffran M; McNair-Scott R; Evans P
Bull World Health Organ; 1995; 73(4):531-40. PubMed ID: 7554027
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Forces in Intradermal Injection Devices: Hydrodynamic Versus Human Factors.
Verwulgen S; Beyers K; Van Mulder T; Peeters T; Truijen S; Dams F; Vankerckhoven V
Pharm Res; 2018 Apr; 35(6):120. PubMed ID: 29671074
[TBL] [Abstract][Full Text] [Related]
13. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection.
Rich JD; Dickinson BP; Carney JM; Fisher A; Heimer R
AIDS; 1998 Dec; 12(17):2345-50. PubMed ID: 9863878
[TBL] [Abstract][Full Text] [Related]
14. Characterization of skin blebs from intradermal jet injection: Ex-vivo studies.
Simmons JA; Davis J; Thomas J; Lopez J; Le Blanc A; Allison H; Slook H; Lewis P; Holtz J; Fisher P; Broderick KE; Marston JO
J Control Release; 2019 Aug; 307():200-210. PubMed ID: 31252035
[TBL] [Abstract][Full Text] [Related]
15. Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial.
McAllister L; Anderson J; Werth K; Cho I; Copeland K; Le Cam Bouveret N; Plant D; Mendelman PM; Cobb DK
Lancet; 2014 Aug; 384(9944):674-81. PubMed ID: 24881803
[TBL] [Abstract][Full Text] [Related]
16. A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant.
Sonoda J; Mizoguchi I; Inoue S; Watanabe A; Sekine A; Yamagishi M; Miyakawa S; Yamaguchi N; Horio E; Katahira Y; Hasegawa H; Hasegawa T; Yamashita K; Yoshimoto T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240448
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous administration of midazolam: a comparison of the Bioject jet injector with the conventional syringe and needle.
Bennett J; Nichols F; Rosenblum M; Condry J
J Oral Maxillofac Surg; 1998 Nov; 56(11):1249-54. PubMed ID: 9820211
[TBL] [Abstract][Full Text] [Related]
18. Injectability of biodegradable in situ forming microparticle systems (ISM).
Rungseevijitprapa W; Bodmeier R
Eur J Pharm Sci; 2009 Mar; 36(4-5):524-31. PubMed ID: 19124076
[TBL] [Abstract][Full Text] [Related]
19. Needle-free delivery of macromolecules through the skin using controllable jet injectors.
Hogan NC; Taberner AJ; Jones LA; Hunter IW
Expert Opin Drug Deliv; 2015; 12(10):1637-48. PubMed ID: 26004884
[TBL] [Abstract][Full Text] [Related]
20. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device.
Cui Z; Baizer L; Mumper RJ
J Biotechnol; 2003 Apr; 102(2):105-15. PubMed ID: 12697387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
